OTHERWISE: A Lost Opportunity for Public Health — The FDA Advisory Committee Report on Menthol | Health Policy and Reform

OTHERWISE: A Lost Opportunity for Public Health — The FDA Advisory Committee Report on Menthol | Health Policy and Reform

Although some public health groups hailed as a public health victory the release of a report on menthol cigarettes by the Tobacco Products Scientific Advisory Committee (TPSAC) of the Food and Drug Administration (FDA),¹ close examination of the report and its recommendations reveals that it actually represents a huge victory for Lorillard, the manufacturer of the leading brand of menthol cigarettes (Newport) — and a disappointing setback for the health of black Americans.